Addie Mitchell, Clinical Nurse Specialist at Breast Cancer Now, led the Loose Women panellists through a live self-check demonstration with Nadia.
The drug lowered breast cancer cases by almost 50% during trials of eligible women over an 11-year period A drug used to treat breast cancer has now been licenced for preventative use and will be offered to almost 300,000 women, in what has been hailed as a ‘major step forward’ for patients with a family history of the disease.
‘Thanks to this initiative, we hope that greater access to anastrozole could enable more women to take risk-reducing steps if they’d like to, helping them live without fear of breast cancer.’ To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video The drug – a 1mg tablet taken once a day for five years – works by cutting down the amount of oestrogen a patient’s body makes by blocking an enzyme called aromatase.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Breast cancer drug for preventative use to be offered to 300,000 womenAddie Mitchell, Clinical Nurse Specialist at Breast Cancer Now, led the Loose Women panellists through a live self-check demonstration with Nadia.
続きを読む »
Breast cancer drug for preventative use to be offered to 300,000 womenAddie Mitchell, Clinical Nurse Specialist at Breast Cancer Now, led the Loose Women panellists through a live self-check demonstration with Nadia.
続きを読む »
NHS to offer new drug that reduces breast cancer risk to womenThe move adds to the NHS's armoury of preventative breast cancer medication, with tamoxifen and raloxifene already licenced to prevent breast cancer
続きを読む »
Almost 300,000 women will be offered drug to reduce risk of developing breast cancerTrials have shown that anastrozole reduces breast cancer cases by 49 per cent over 11 years among eligible women
続きを読む »
'Repurposed' drug that could prevent breast cancer to be offered to nearly 300,000 womenThe NHS estimates 2,000 cases would be prevented if 25% of eligible women in England take up the offer - and half of those take the drug for the recommended five years.
続きを読む »
Women may not recognize non-lump symptoms of breast cancerFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State University Comprehensive Cancer Center: The James (OSUCCC-James).
続きを読む »